[1」李家泰.抗生素的合理应用.中国临床药理学杂志，1990，6：197. [2]Robert S.β-lactarnase inhibitors and reversal of antibiotic resis-tance厂Trends Pharmacal Sci,1991,12:227. [3]Livermore DM.Determinants of the activity of β-lactarnase in-hibitor combination.J Antimicrob Chemother,1993,31:9. [4]Bush K,Macalintal C,Rsmussen BA,et al,Kinetics interactions of tawbactam withβ-lactamases from all major structural class- es.Antimicrob Agents Chemother,1993,37:851. [5]Greenwood D.For debate.J Antimicrob Chemother,1996,38:17. [6]Li JT,Moosdeen F.The effect of inhibitor of β-lactamase on β-lactamase extracts and on intact cells.J Antimicrob Chemother, 1982,9:287. [7]Yamaguchi A,Hirata T,Sawai T.Kinetic studies on inactivation of Citrobacter freundii cephalosporines by sulbactum.Antimicrob 人rents C,hemother,1983,24:23. [8]Engel PC.Enxyme kinetics.The steadystate approach.2nd ed.London: Chapman Ha11,1981:14-25. [9]Bush K,Skyes RB.Methodology for the study of β-lactamase.Antimicrob人rents Caeemother,1986,30:6. [10〕阎淑雅，李家泰.β-内酰胺酶在细菌耐药中的作用及开展β-内酰胺酶动力研究的意义.中国抗生素杂志，1989，14：68.